These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Barza M; Kane A; Baum JL Am J Ophthalmol; 1977 Mar; 83(3):407-13. PubMed ID: 848547 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of triazene cytostatics. Kolar GF; Wildschütte M Adv Exp Med Biol; 1981; 136 Pt B():1285-96. PubMed ID: 7344512 [No Abstract] [Full Text] [Related]
6. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Ishii K; Matsuo H; Fukaya Y; Tanaka S; Sakaki H; Waki M; Araie M Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1169-77. PubMed ID: 12601046 [TBL] [Abstract][Full Text] [Related]
7. Intraocular penetration of gentamicin after subconjunctibal and retrobulbar injection . Barza M; Kane A; Baum J Am J Ophthalmol; 1978 Apr; 85(4):541-7. PubMed ID: 418687 [TBL] [Abstract][Full Text] [Related]
8. Dacarbazine (DTIC) in malignant melanoma. Drug Ther Bull; 1976 May; 14(10):39-40. PubMed ID: 976088 [No Abstract] [Full Text] [Related]
9. The penetration of steroids into the rabbit's vitreous, choroid and retina following retrobulbar injection. I. Barry A; Rousseau A; Babineau LM Can J Ophthalmol; 1969 Oct; 4(4):365-9. PubMed ID: 5822457 [No Abstract] [Full Text] [Related]
10. Stochastic compartmental modeling of the disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). McInnis B; Kapadia A; El-Asfouri S; Loo TL Cancer Chemother Rep; 1975; 59(4):843-5. PubMed ID: 1175174 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Ghate D; Brooks W; McCarey BE; Edelhauser HF Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of disseminated malignant melanoma]. Chauvergne J; Clavel B; Klein T; Pammatau E Nouv Presse Med; 1978 Sep; 7(30):2658-9. PubMed ID: 693309 [No Abstract] [Full Text] [Related]
13. [Treatment of malignant melanomas. Trial of D.T.I.C. by intra-arterial infusion]. Banzet P; Ricbourg B; Jacquillat C; Dufourmentel C Nouv Presse Med; 1975 May; 4(20):1477-80. PubMed ID: 1215144 [TBL] [Abstract][Full Text] [Related]
14. Observations on the "in vitro" oxidative N-demethylation of 4-(3, 3-dimethyl-1-triazeno)-imidazole-5-carboxamide (DIC, NSC 45388). Giraldi T; Nisi C; Sava G Pharmacol Res Commun; 1976 Feb; 8(1):25-9. PubMed ID: 1026951 [No Abstract] [Full Text] [Related]
15. Massive upper gastrointestinal bleeding during chemotherapy for malignant melanoma. Goldman SL; Pollak EW; Wolfman EF Am Surg; 1977 Nov; 43(11):768-70. PubMed ID: 303488 [No Abstract] [Full Text] [Related]
16. [Results with new cytotoxic agents]. Brufman G; Biran S; Ratzkowski E Harefuah; 1976 Nov; 91(9):268-70. PubMed ID: 1010474 [No Abstract] [Full Text] [Related]
17. [Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent]. Klepp O Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1550-1. PubMed ID: 1179374 [No Abstract] [Full Text] [Related]